197 related articles for article (PubMed ID: 28883415)
1. High expression FUT1 and B3GALT5 is an independent predictor of postoperative recurrence and survival in hepatocellular carcinoma.
Kuo HH; Lin RJ; Hung JT; Hsieh CB; Hung TH; Lo FY; Ho MY; Yeh CT; Huang YL; Yu J; Yu AL
Sci Rep; 2017 Sep; 7(1):10750. PubMed ID: 28883415
[TBL] [Abstract][Full Text] [Related]
2. High expression of embryonic stem cell marker SSEA3 confers poor prognosis and promotes epithelial mesenchymal transition in hepatocellular carcinoma.
Hung TH; Huang Y; Yeh CT; Yeh CN; Yu J; Lin CC; Chiou SP; Chiang PY; Hung JT; Yu AL
Biomed J; 2024 Apr; 47(2):100612. PubMed ID: 37290529
[TBL] [Abstract][Full Text] [Related]
3. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of activated Cdc42-associated kinase1 (Ack1) predicts tumor recurrence and poor survival in human hepatocellular carcinoma.
Wang B; Xu T; Liu J; Zang S; Gao L; Huang A
Pathol Res Pract; 2014 Dec; 210(12):787-92. PubMed ID: 25445114
[TBL] [Abstract][Full Text] [Related]
5. High B3GALT5 expression confers poor clinical outcome and contributes to tumor progression and metastasis in breast cancer.
Liao YM; Wang YH; Hung JT; Lin YJ; Huang YL; Liao GS; Hsu YL; Wu JC; Yu AL
Breast Cancer Res; 2021 Jan; 23(1):5. PubMed ID: 33413566
[TBL] [Abstract][Full Text] [Related]
6. CXCL17 expression predicts poor prognosis and correlates with adverse immune infiltration in hepatocellular carcinoma.
Li L; Yan J; Xu J; Liu CQ; Zhen ZJ; Chen HW; Ji Y; Wu ZP; Hu JY; Zheng L; Lau WY
PLoS One; 2014; 9(10):e110064. PubMed ID: 25303284
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of microRNA-155 promotes cancer cell invasion and predicts poor survival of hepatocellular carcinoma following liver transplantation.
Han ZB; Chen HY; Fan JW; Wu JY; Tang HM; Peng ZH
J Cancer Res Clin Oncol; 2012 Jan; 138(1):153-61. PubMed ID: 22071603
[TBL] [Abstract][Full Text] [Related]
8. CXCR2-CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma.
Li L; Xu L; Yan J; Zhen ZJ; Ji Y; Liu CQ; Lau WY; Zheng L; Xu J
J Exp Clin Cancer Res; 2015 Oct; 34():129. PubMed ID: 26503598
[TBL] [Abstract][Full Text] [Related]
9. The Overexpression of CCAR1 in Hepatocellular Carcinoma Associates with Poor Prognosis.
Ha SY; Kim JH; Yang JW; Kim J; Kim B; Park CK
Cancer Res Treat; 2016 Jul; 48(3):1065-73. PubMed ID: 26511806
[TBL] [Abstract][Full Text] [Related]
10. DEP domain containing 1 is a novel diagnostic marker and prognostic predictor for hepatocellular carcinoma.
Yuan SG; Liao WJ; Yang JJ; Huang GJ; Huang ZQ
Asian Pac J Cancer Prev; 2014; 15(24):10917-22. PubMed ID: 25605201
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of microRNA-15b by hepatitis B virus X enhances hepatocellular carcinoma proliferation via fucosyltransferase 2-induced Globo H expression.
Wu CS; Yen CJ; Chou RH; Chen JN; Huang WC; Wu CY; Yu YL
Int J Cancer; 2014 Apr; 134(7):1638-47. PubMed ID: 24122375
[TBL] [Abstract][Full Text] [Related]
12. Aberrant KIF20A expression might independently predict poor overall survival and recurrence-free survival of hepatocellular carcinoma.
Lu M; Huang X; Chen Y; Fu Y; Xu C; Xiang W; Li C; Zhang S; Yu C
IUBMB Life; 2018 Apr; 70(4):328-335. PubMed ID: 29500859
[TBL] [Abstract][Full Text] [Related]
13. High NEK2 Expression Is a Predictor of Tumor Recurrence in Hepatocellular Carcinoma Patients After Hepatectomy.
Wubetu GY; Morine Y; Teraoku H; Yoshikawa M; Ishikawa D; Yamada S; Ikemoto T; Saito YU; Imura S; Shimada M
Anticancer Res; 2016 Feb; 36(2):757-62. PubMed ID: 26851035
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of a potent multi-mRNA signature for the prediction of early relapse in hepatocellular carcinoma.
Cai J; Tong Y; Huang L; Xia L; Guo H; Wu H; Kong X; Xia Q
Carcinogenesis; 2019 Jul; 40(7):840-852. PubMed ID: 31059567
[TBL] [Abstract][Full Text] [Related]
15. A six-gene-based prognostic signature for hepatocellular carcinoma overall survival prediction.
Wang Z; Teng D; Li Y; Hu Z; Liu L; Zheng H
Life Sci; 2018 Jun; 203():83-91. PubMed ID: 29678742
[TBL] [Abstract][Full Text] [Related]
16. Clinical Significance of TRMT6 in Hepatocellular Carcinoma: A Bioinformatics-Based Study.
Wang Y; Huang Q; Deng T; Li BH; Ren XQ
Med Sci Monit; 2019 May; 25():3894-3901. PubMed ID: 31128068
[TBL] [Abstract][Full Text] [Related]
17. ALK gene copy number gain and its clinical significance in hepatocellular carcinoma.
Jia SW; Fu S; Wang F; Shao Q; Huang HB; Shao JY
World J Gastroenterol; 2014 Jan; 20(1):183-92. PubMed ID: 24415871
[TBL] [Abstract][Full Text] [Related]
18. Gene expression in nontumoral liver tissue and recurrence-free survival in hepatitis C virus-positive hepatocellular carcinoma.
Tsuchiya M; Parker JS; Kono H; Matsuda M; Fujii H; Rusyn I
Mol Cancer; 2010 Apr; 9():74. PubMed ID: 20380719
[TBL] [Abstract][Full Text] [Related]
19. Expression of Aurora B and alternative variant forms in hepatocellular carcinoma and adjacent tissue.
Yasen M; Mizushima H; Mogushi K; Obulhasim G; Miyaguchi K; Inoue K; Nakahara I; Ohta T; Aihara A; Tanaka S; Arii S; Tanaka H
Cancer Sci; 2009 Mar; 100(3):472-80. PubMed ID: 19134008
[TBL] [Abstract][Full Text] [Related]
20. Expression and prognostic significance of vascular endothelial growth factor receptor 1 in hepatocellular carcinoma.
Li T; Zhu Y; Qin CY; Yang Z; Fang A; Xu S; Ren W
J Clin Pathol; 2012 Sep; 65(9):808-14. PubMed ID: 22734007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
